Duker Jay S. - Insider Non-Derivative Transactions at EyePoint Pharmaceuticals, Inc. (EYPT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 10, 2024, Duker Jay S.'s relationship to EyePoint Pharmaceuticals, Inc. (EYPT) is Director,Officer (President and CEO), and currently has 46,086 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other EYPT insiders.

Data Source: SEC.
Duker Jay S. - Insider Non-Derivative Transactions of EYPT Common Stock
Duker Jay S. - Insider Non-Derivative Transactions at EYPT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 11, 2024 F -- (Common Stock) 8059 8.69 38027
Jul 11, 2024 M -- (Common Stock) 16666 0 46086
Feb 28, 2024 G -- (Common Stock) 2500 0 22500
Feb 28, 2024 G -- (Common Stock) 2500 0 29420
Feb 21, 2024 G -- (Common Stock) 20000 0 20000
Feb 21, 2024 G -- (Common Stock) 20000 0 31920
Feb 10, 2024 M -- (Common Stock) 7000 0 50486
Feb 10, 2024 F -- (Common Stock) 1458 28.8 51920
Feb 10, 2024 F -- (Common Stock) 2075 28.8 53378
Feb 10, 2024 M -- (Common Stock) 4967 0 55453
Jan 7, 2024 F -- (Common Stock) 6528 20.4 43486
Jan 7, 2024 M -- (Common Stock) 20793 0 50014
Feb 10, 2023 M -- (Common Stock) 7000 0 28402
Feb 10, 2023 F -- (Common Stock) 1722 4.17 29221
Feb 10, 2023 F -- (Common Stock) 2426 4.17 30943
Feb 10, 2023 M -- (Common Stock) 4967 0 33369